Clinical Trial Update: Piracetam for Treatment Tardive Dyskinesia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating piracetam for tardive dyskinesia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tardive Dyskinesia

Drugs mentioned

• Piracetam (piracetam)

Snippet

Sponsor: Beersheva Mental Health Center | Conditions: Tardive Dyskinesia | Phase 3 | Status: COMPLETED